IL281349B
Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO2006056794A1 | Cites | World Intellectual Property Organization (WIPO) | YX | Search report | 2,5-16,20-26,31-50 |
| US2014142186A1 | Cites | United States of America | YX | Search report | 2,5-16,20-26,31-50 |
| CA2763894A1 | Cites | Canada | YX | Search report | 2,5-16,20-26,31-50 |
| ZHU Q. ET AL.,, INTESTINAL DECONTAMINATION INHIBITS TLR4 DEPENDENT FIBRONECTIN - MEDIATED CROSS-TALK BETWEEN STELLATE CELLS AND ENDOTHELIAL CELLS IN LIVER FIBROSIS IN MICE, 13 December 2011 (2011-12-13) | Non-patent | – | – | Search report | – |
46 members in 18 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 201462083814 | United States of America | P | |
| 201462083814 | United States of America | P | |
| 62083814 | United States of America | – | |
| 2015062223 | United States of America | W | |
| 2015062223 | United States of America | W | |
| 62083814 | – | – | – |
| PCTUS2015062223 | – | – | – |
| US201462083814P | – | – | – |
| WO2015US62223 | – | – | – |
Members46
| Document | Office | Kind | |
|---|---|---|---|
| CA2968544A1 | Canada | A1 | |
| WO2016085887A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2015353703A1 | Australia | A1 | |
| SG11201704011XA | Singapore | A | |
| IL252405A0 | Israel | A0 | |
| IL252405D0 | Israel | D0 | |
| KR20170095894A | Republic of Korea | A | |
| CN107206021A | China | A | |
| EP3223829A1 | European Patent Office (EPO) | A1 | |
| EA201790913A1 | Eurasian Patent Organization (EAPO) | A1 | |
| JP2017535575A | Japan | A | |
| US2017354627A1 | United States of America | A1 | |
| BR112017010761A2 | Brazil | A2 | |
| MX2017006685A | Mexico | A | |
| EP3223829A4 | European Patent Office (EPO) | A4 | |
| HK1243651A | Hong Kong, China | A | |
| HK1243651A1 | Hong Kong, China | A1 | |
| US10039735B2 | United States of America | B2 | |
| US2019070142A1 | United States of America | A1 | |
| EP3223829B1 | European Patent Office (EPO) | B1 | |
| US10525029B2 | United States of America | B2 | |
| DK3223829T3 | Denmark | T3 | |
| ES2769000T3 | Spain | T3 | |
| US2020206175A1 | United States of America | A1 | |
| EP3685841A1 | European Patent Office (EPO) | A1 | |
| JP2020169180A | Japan | A | |
| MX2020010194A | Mexico | A | |
| MX2020010194A | Mexico | A | |
| JP6797117B2 | Japan | B2 | |
| IL252405A | Israel | A | |
| IL252405B | Israel | B | |
| AU2015353703B2 | Australia | B2 | |
| IL281349A | Israel | A | |
| IL281349D0 | Israel | D0 | |
| US11040021B2 | United States of America | B2 | |
| AU2021203938A1 | Australia | A1 | |
| NZ732632A | New Zealand | A | |
| CN107206021B | China | B | |
| ZA201703779B | South Africa | B | |
| CN113633777A | China | A | |
| IL281349BThis record | Israel | B | |
| BR112017010761B1 | Brazil | B1 | |
| JP7199400B2 | Japan | B2 | |
| KR102487376B1 | Republic of Korea | B1 | |
| KR20230018526A | Republic of Korea | A | |
| MX375838B | Mexico | B |
Numbers
- Publication
- 281349
- Publication, DOCDB
- 281349
- Publication, EPODOC
- IL281349
- Application
- 281349
- Application, DOCDB
- 28134921
- Application, EPODOC
- IL20210281349
Titles2
- English
- TREATMENT OF DISEASES ASSOCIATED WITH HEPATIC STELLATE CELL ACTIVATION USING AMMONIA-LOWERING THERAPIES
- Hebrew
- טיפול במחלות הקשורות לפעילות תא דמוי כוכב כבדי באמצעות טיפולים להורדת אמוניה
Classification
- CPC, 15
- A61K31/216
- A61K33/42
- A61K31/192
- A61K31/198
- A61K31/437
- A61K9/0053
- A61P1/16
- A61K31/7004
- A61K31/7016
- A61K9/0019
- A61K45/06
- A61P1/10
- A61P35/00
- A61P43/00
- A61K2300/00
- IPC, 13
- A61K31 7016
- A61K31 216
- A61K9 00
- A61K45 06
- A61K33 42
- A61K31 198
- A61K31 437
- A61K31 7004
- A61K31 192
- A61P1 10
- A61P1 16
- A61P35 00
- A61P43 00